Member of the Board since 2018.
Viviane Monges was born in 1963 and is a French national. She received an undergraduate degree in business administration as well as an MBA with a major in finance from Ecole Supérieure de Commerce de Paris (ESCP). In the beginning of her career she served in a wide variety of roles in Asia, Latin America, Europe and the United States.
Viviane Monges has over 30 years of financial management experience, predominantly within the pharmaceutical industry. She joined Wyeth Pharmaceuticals Inc. in 1997 and held several leadership roles, including CFO of the Europe Region unit and CFO of the Global Pharma Business unit. From 2006 to 2010, Viviane Monges was with Novartis A/G as Europe CFO and then as Global Division CFO of the OTC Division. In 2010, she joined Galderma S.A., a multinational dermatology company which was later acquired by Nestlé S.A., as Group CFO. From 2015 and onwards, Viviane Monges served as CFO of the Nestlé Business Excellence Division.
In addition to the Novo Holdings A/S Board, Viviane Monges is currently a board member and audit committee member of Union Chimique Belge Biopharmaceutical Company S.A. (UCB), based in Belgium; board member of ADC Therapeutics, based in Switzerland; board member and audit committee member of DBV Technologies, based in France; and board member and Chair of the Audit Committee of Voluntis S.A., also based in France.